Syneron

Syneron Medical to Report Third Quarter 2012 Financial Results on November 7, 2012

YOKNEAM, Israel, Oct. 29, 2012 (GLOBE NEWSWIRE) -- Syneron Medical Ltd. (Nasdaq:ELOS), the leading global aesthetic device company, today announced that it will release third quarter 2012 financial results before the market opens on Wednesday, November 7, 2012. The earnings release will be available on Syneron's website at

Syneron

Syneron to Present at Two Upcoming Conferences

YOKNEAM, Israel, March 21, 2012 (GLOBE NEWSWIRE) -- Syneron Medical Ltd. (Nasdaq:ELOS), the leading global aesthetic device company, announced today that Louis P. Scafuri, Chief Executive Officer, is scheduled to present at two upcoming investor conferences. The first will be at the 2012 Maxim Group Growth Conference in New York City.